Clinical trials
Phase 2 Lymphoma, T-Cell trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
7 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2007 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2018 | 2 |
| 2019 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 4 |
| Enrolling by invitation | 1 |
| Terminated | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Acrotech Biopharma Inc. | 1 |
| Autolus Limited | 1 |
| Celgene | 1 |
| Janssen Research & Development, LLC | 1 |
| Royal Marsden NHS Foundation Trust | 1 |
| SecuraBio | 1 |
| miRagen Therapeutics, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, T-Cell | 7 |
| Lymphoma | 4 |
| Lymphoma, T-Cell, Peripheral | 3 |
| Lymphoma, T-Cell, Cutaneous | 2 |
| Enteropathy-Associated T-Cell Lymphoma | 1 |
| Immune System Diseases | 1 |
| Immunoblastic Lymphadenopathy | 1 |
| Immunoproliferative Disorders | 1 |
| Lymphatic Diseases | 1 |
| Lymphoma, Large-Cell, Anaplastic | 1 |
Trials
Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.